The effects of aprotinin on follicle-stimulating hormone binding and signal transduction in bovine calf testis.

Aprotinin (bovine pancreatic trypsin inhibitor), a serine protease inhibitor, caused a dose-dependent inhibition of [125I]human FSH ([ 125I]hFSH) binding to 1) an FSH receptor-enriched light membrane fraction prepared from bovine calf testes homogenates, 2) Triton X-100-solubilized FSH receptor, and 3) proteoliposomes containing incorporated FSH receptor-G-protein-adenylate cyclase (AC) complexes. Equilibrium binding studies with the solubilized receptor indicated that the effect of aprotinin on [125I]hFSH binding was due to a decrease in the Ka of the receptor, with no change in FSH-binding capacity. The rate of association of [125I]hFSH with its receptor was reduced by 50% in the presence of aprotinin, but no effect on dissociation of FSH-receptor complexes was evident. Aprotinin, at a concentration (250 microM) that inhibited binding of [125I]hFSH to the membrane receptor by 25%, completely inhibited basal, fluoride-stimulated and FSH-stimulated AC activity. However, aprotinin, at a concentration (50 microM) that had little effect on [125I]hFSH binding, markedly enhanced basal AC activity (3.4-fold) to the level of fluoride and FSH stimulation. Aprotinin did not inhibit [3H]5'-guanylylimidodiphosphate binding to FSH receptor-enriched membranes, suggesting that its effects on the affinity of the receptor for FSH and on AC activation were not mediated through an interaction with FSH receptor-associated G-protein. No serine protease activity could be detected in any of the receptor or hormone preparations used in this study. The ability of aprotinin to inhibit binding of [125I]hFSH to the Triton X-100-solubilized receptor and to the soluble receptor incorporated into proteoliposomes as well as to the FSH receptor-enriched membrane fraction, all of which are free of serine protease activity, is consistent with the notion that aprotinin may directly interact with the FSH receptor to sterically hinder binding of FSH. Furthermore, the apparent direct effect of aprotinin on basal as well as FSH-stimulated AC activity suggests its general usefulness in studies on the mechanism of signal transduction for ligands thought to operate via the cAMP second messenger system.

[1]  L. Reichert,et al.  Reconstitution of hormone-responsive detergent-solubilized follicle stimulating hormone receptors into liposomes. , 1988, Molecular endocrinology.

[2]  L. Reichert,et al.  Regulation of follicle-stimulating hormone binding to receptors on bovine calf testis membranes by cholera toxin-sensitive guanine nucleotide binding protein. , 1988, Molecular endocrinology.

[3]  J. Wilks,et al.  Aprotinin antagonizes the binding of human chorionic gonadotropin to its receptor. , 1987, Endocrinology.

[4]  A. Schneyer,et al.  Solubilization of functional and stable follitropin receptors from light membranes of bovine calf testis. , 1986, The Journal of biological chemistry.

[5]  P. Sluss,et al.  Electrophoretic purification of radioiodinated follicle-stimulating hormone for radioligand receptor assay and radioimmunoassay. , 1986, Endocrinology.

[6]  J. Campbell,et al.  Inhibition of gonadotropin-stimulated adenylate cyclase by dansyl-arginyl-(4'-ethyl)piperidine amide (DAPA). , 1984, Biology of reproduction.

[7]  P. Fletcher,et al.  Cellular processing of follicle-stimulating hormone by Sertoli cells in serum-free culture , 1984, Molecular and Cellular Endocrinology.

[8]  P. McIlroy,et al.  Effects of dansyl-arginyl-(4'-ethyl)piperidine amide on gonadotropin binding to rat tissues. , 1983, Endocrinology.

[9]  J. Calvo,et al.  Measurement of specific radioactivities in labelled hormones by self-displacement analysis. , 1983, The Biochemical journal.

[10]  D. Crowell,et al.  Effects of proteolytic enzymes and protease inhibitors on bovine thyroid adenylate cyclase activity. , 1983, Endocrinology.

[11]  J. Dias,et al.  Inhibition of FSH action on granulosa cells by low molecular weight components of follicular fluid , 1982, Molecular and Cellular Endocrinology.

[12]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[13]  J. Daly,et al.  Effect of proteases and protease inhibitors on adenylate cyclase activity in rat cerebral cortical membranes. , 1979, Archives of biochemistry and biophysics.

[14]  L. Birnbaumer,et al.  Effects of trypsin, protease inhibitors and ethanol on corpus luteum adenylyl cyclase. , 1979, Biology of reproduction.

[15]  N. Richert,et al.  Proteolytic enzyme activation of rat ovarian adenylate cyclase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Richert,et al.  Protease inhibitors block hormonal activation of adenylate cyclase. , 1977, Biochemical and biophysical research communications.

[17]  H. Abou-Issa,et al.  Solubilization and some characteristics of the follitropin receptor from calf testis. , 1977, The Journal of biological chemistry.

[18]  D. Stengel,et al.  Proteolytic activation of rat liver adenylate cyclase by a contaminant of crude collagenase from Clostridium histolyticum. , 1977, The Journal of biological chemistry.

[19]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[20]  I. Snir,et al.  Studies on the basic trypsin inhibitor of bovine pancreas and its interaction with trypsin. , 1967, Archives of biochemistry and biophysics.

[21]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[22]  J. Northrop,et al.  ISOLATION FROM BEEF PANCREAS OF CRYSTALLINE TRYPSINOGEN, TRYPSIN, A TRYPSIN INHIBITOR, AND AN INHIBITOR-TRYPSIN COMPOUND , 1936, The Journal of general physiology.